Evidence map›Paper›PMID 35449542›Full record

ArticleFrontiers in nutrition2022

Gene-Edited Meat: Disentangling Consumers' Attitudes and Potential Purchase Behavior.

Daniel Martin-Collado, Tim J Byrne, Jonh J Crowley, Tom Kirk, Guillermo Ripoll, C B A Whitelaw

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Genome-Edited Fish in the Field.Current issues in molecular biology · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel Martin-ColladoDepartment of Animal Science, Agrifood Research and Technology Centre of Aragon (CITA), Zaragoza, Spain.
Tim J ByrneAbacusBio International Limited, Roslin Innovation Centre, Edinburgh, United Kingdom.
Jonh J CrowleyAbacusBio International Limited, Roslin Innovation Centre, Edinburgh, United Kingdom.
Tom KirkAbacusBio International Limited, Roslin Innovation Centre, Edinburgh, United Kingdom.
Guillermo RipollDepartment of Animal Science, Agrifood Research and Technology Centre of Aragon (CITA), Zaragoza, Spain.
C B A WhitelawThe Roslin Institute, Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Edinburgh, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel gene-editing (GE) technologies provide promising opportunities to increase livestock productivity and to tackle several global livestock production sustainability and food security challenges. However, these technologies, as with previous genetic modification technologies in food production, are very likely to generate social controversy and opposition toward their use in the meat industry. Here, we explored public attitudes and consumption predisposition toward gene-edited meat products and their potential added benefits to livestock farming. Our results show that societal perception currently comes as a package, where the use of gene-editing technology acts as an extrinsic cue of meat products quality, and is used to make a range of inferences about all quality facets at once. Although consumers with anti-GE attitudinal positions generally were not sensitive to price discounts or added benefits, added benefits increased the consumption predisposition of most moderate and pro-GE consumers, where benefits related to animal welfare had larger effects than those relating to the environment or human health issues.

Indexed as

added benefitsCRISPRgenetic modification (GM)livestock biotechnologywillingness to pay (WTP)

Identifiers

PMID35449542
PMCPMC9017286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.